TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08956 XX ID T08956 XX DT 23.05.2006 (created); ran. DT 09.01.2014 (updated); spk. CO Copyright (C), QIAGEN. XX FA TAFII250 XX SY CCG1; p250; TAF(II)250; TAF-250; TAF1; TAFII250; TBP-associated factor 250. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G009204 TAF1; HGNC: TAF1. XX CL C0015; HMG; 4.1.3.0.5. XX IN T02727 cyclinT1; human, Homo sapiens. IN T06586 gfi1b; human, Homo sapiens. IN T05056 Max; human, Homo sapiens. IN T16713 MEF-2C; human, Homo sapiens. IN T09260 MEF-2D; human, Homo sapiens. IN T13888 pax6; Mammalia. IN T16157 TAF2; human, Homo sapiens. IN T00784 TAFII100; human, Homo sapiens. IN T28810 TAFII135; human, Homo sapiens. IN T00782 TAFII55; human, Homo sapiens. IN T09103 TAFII70; human, Homo sapiens. XX MX M04770 V$TAF1_01. MX M04794 V$TAF1_03. MX M04848 V$TAF1_04. MX M04888 V$TAF1_05. MX M04893 V$TAF1_06. MX M04916 V$TAF1_07. XX DR TRANSPATH: MO000081793. DR UniProtKB: P21675; XX RN [1]; RE0047734. RX PUBMED: 9388200. RA Leveillard T., Wasylyk B. RT The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. RL J. Biol. Chem. 272:30651-30661 (1997). RN [2]; RE0048297. RX PUBMED: 10359315. RA Cvekl A., Kashanchi F., Brady J. N., Piatigorsky J. RT Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein. RL Invest. Ophthalmol. Vis. Sci. 40:1343-1350 (1999). RN [3]; RE0048322. RX PUBMED: 15899866. RA Frontini M., Soutoglou E., Argentini M., Bole-Feysot C., Jost B., Scheer E., Tora L. RT TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. RL Mol. Cell. Biol. 25:4638-4649 (2005). XX //